|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 982.22 USD | -1.54% |
|
-6.11% | +27.23% |
| Dec. 09 | Health Care Down as Traders Eye Deal Risks - Health Care Roundup | DJ |
| Dec. 09 | Eli Lilly and Company to Build $6 Billion Facility to Manufacture Active Pharmaceutical Ingredients in Alabama | CI |
Chart calendar Eli Lilly and Company
Upcoming events on Eli Lilly and Company
| Today | San Antonio Breast Cancer Symposium - Poster No :#PS1-08-08 | Add to your calendar Google Apple ICS format |
| Today | San Antonio Breast Cancer Symposium - Poster No :#PS1-03-03 | Add to your calendar Google Apple ICS format |
| Today | San Antonio Breast Cancer Symposium - Poster No : #PS1-08-24 | Add to your calendar Google Apple ICS format |
| Today | San Antonio Breast Cancer Symposium - Poster No : #PS1-12-08 | Add to your calendar Google Apple ICS format |
| 2025-12-11 | San Antonio Breast Cancer Symposium - Poster No : #PD5-08 | Add to your calendar Google Apple ICS format |
| 2025-12-12 | San Antonio Breast Cancer Symposium - Oral No : #GS3-08 | Add to your calendar Google Apple ICS format |
| 2025-12-12 | San Antonio Breast Cancer Symposium - Poster No : #PS5-04-08 | Add to your calendar Google Apple ICS format |
| 2025-12-12 | San Antonio Breast Cancer Symposium - Poster No :#PS5-05-09 | Add to your calendar Google Apple ICS format |
| 2026-02-10 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-04-22 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-08-03 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-11-02 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on Eli Lilly and Company
| 2025-12-09 | American Society of Hematology Meeting - Abstract No: LBA-3 |
| 2025-12-08 | American Society of Hematology Meeting - Abstract No: 5684 |
| 2025-12-08 | American Society of Hematology Meeting - Abstract No: 5670 |
| 2025-12-08 | American Society of Hematology Meeting - Abstract No: 5673 |
| 2025-12-07 | American Society of Hematology Meeting - Abstract No: 3878 |
| 2025-12-07 | American Society of Hematology Meeting - Abstract No: 683 |
| 2025-12-07 | American Society of Hematology Meeting - Abstract No: 665 |
| 2025-12-07 | American Society of Hematology Meeting - Abstract No: 680 |
| 2025-12-06 | American Society of Hematology Meeting - Abstract No: 2704 |
| 2025-12-06 | American Society of Hematology Meeting - Abstract No: 2725 |
| 2025-12-06 | American Society of Hematology Meeting - Abstract No: 2115 |
| 2025-12-06 | American Society of Hematology Meeting - Abstract No: 226 |
| 2025-12-06 | American Society of Hematology Meeting - Abstract No: 225 |
| 2025-12-06 | American Society of Hematology Meeting - Abstract No: 89 |
| 2025-12-02 | Citi Global Healthcare Conference |
| 2025-11-13 | Ex-dividend day |
| 2025-10-30 | Q3 2025 Earnings Call |
| 2025-10-30 | Q3 2025 Earnings Release |
| 2025-10-20 | European Society of Medical Oncology Congress - Abstract No - #496P |
| 2025-10-20 | European Society of Medical Oncology Congress - Abstract No - #236eP |
Past dividends on Eli Lilly and Company
| 2025-11-13 | Quarterly 1.5 USD |
| 2025-08-14 | Quarterly 1.5 USD |
| 2025-05-15 | Quarterly 1.5 USD |
| 2025-02-13 | Quarterly 1.5 USD |
| 2024-11-14 | Quarterly 1.3 USD |
| 2024-08-14 | Quarterly 1.3 USD |
| 2024-05-14 | Quarterly 1.3 USD |
| 2024-02-13 | Quarterly 1.3 USD |
| 2023-11-13 | Quarterly 1.13 USD |
| 2023-08-13 | Quarterly 1.13 USD |
| 2023-05-11 | Quarterly 1.13 USD |
| 2023-02-13 | Quarterly 1.13 USD |
| 2022-11-13 | Quarterly 0.98 USD |
| 2022-08-11 | Quarterly 0.98 USD |
| 2022-05-12 | Quarterly 0.98 USD |
| 2022-02-13 | Quarterly 0.98 USD |
| 2021-11-11 | Quarterly 0.85 USD |
| 2021-08-11 | Quarterly 0.85 USD |
| 2021-05-12 | Quarterly 0.85 USD |
| 2021-02-10 | Quarterly 0.85 USD |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 28 541 28 641 -0.35% | 34 124 33 585 1.6% | 45 043 45 075 -0.07% | 63 578 | 75 888 | 88 749 |
|
EBITDA Million USD | Released Forecast Spread | 9 473 9 494 -0.23% | 8 584 8 418 1.98% | 16 079 16 083 -0.02% | 28 647 | 37 481 | 44 977 |
|
EBIT Million USD | Released Forecast Spread | 7 950 8 164 -2.62% | 7 057 6 928 1.86% | 14 313 14 193 0.84% | 26 669 | 34 732 | 41 690 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 6 806 7 084 -3.93% | 6 555 6 311 3.86% | 12 680 14 139 -10.32% | 25 049 | 32 083 | 38 727 |
|
Net income Million USD | Released Forecast Spread | 6 245 6 102 2.35% | 5 240 5 307 -1.26% | 10 590 11 007 -3.78% | 20 399 | 27 899 | 33 987 |
|
EPS USD | Released Forecast Spread | 6,90 6,60 4.57% | 5,80 6,04 -3.92% | 11,7 12,3 -4.87% | 22,9 | 31,7 | 38,2 |
| Announcement Date | 02/02/23 | 06/02/24 | 06/02/25 | - |
Quarterly results
| Fiscal Period | September | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 8 768 8 930 -1.81% | 11 303 9 968 13.4% | 11 439 12 119 -5.61% | 13 533 13 431 0.76% | 12 729 12 722 0.05% | 15 558 14 669 6.06% | 17 601 16 069 9.53% | 17 770 | 17 458 | 18 719 | 19 383 | 20 647 |
|
EBITDA Million USD | Released Forecast Spread | 3 049 2 827 7.84% | 4 703 3 848 22.22% | 2 214 2 501 -11.48% | 6 113 6 205 -1.48% | 4 316 5 052 -14.58% | 7 467 6 892 8.35% | 8 320 7 087 17.39% | 8 908 | 8 892 | 9 646 | 10 573 | 11 957 |
|
EBIT Million USD | Released Forecast Spread | 2 648 2 674 -0.96% | 4 289 3 028 41.63% | 1 747 2 347 -25.55% | 5 628 5 532 1.74% | 3 853 4 172 -7.65% | 6 989 6 178 13.13% | 7 850 6 531 20.2% | 7 809 | 8 266 | 9 078 | 10 079 | 10 375 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2 536 2 455 3.3% | 3 517 3 065 14.75% | 1 588 | 5 039 5 429 -7.19% | 3 456 5 074 -31.89% | 6 776 5 688 19.14% | 7 232 6 874 5.21% | 7 685 | ||||
|
Net income Million USD | Released Forecast Spread | 2 243 2 058 8.99% | 2 967 2 415 22.87% | 970 1 177 -17.58% | 4 410 4 600 -4.13% | 2 759 3 322 -16.94% | 5 661 4 833 17.13% | 5 583 5 299 5.34% | 6 284 | 5 704 | 6 676 | 7 326 | |
|
EPS USD | Released Forecast Spread | 2,48 2,44 1.64% | 3,28 2,72 20.64% | 1,07 1,54 -30.7% | 4,88 5,01 -2.59% | 3,06 4,11 -25.6% | 6,29 5,50 14.46% | 6,21 5,93 4.66% | 7,25 | 7,78 | 8,26 | 9,09 | 10,5 |
| Announcement Date | 30/04/24 | 08/08/24 | 30/10/24 | 06/02/25 | 01/05/25 | 07/08/25 | 30/10/25 | - | - | - | - | - |
| 2026-01-05 | Q3 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 2026-01-11 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-15 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-20 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 2026-01-20 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-21 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-21 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-21 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-22 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-26 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past sector events for Eli Lilly and Company
| 2025-12-08 | Q2 2026 Earnings Release | |
| 2025-12-05 | November 2025 Sales and Revenue Release | |
| 2025-11-30 | Q3 2025 Earnings Release | |
| 2025-11-27 | Q2 2026 Earnings Release | |
| 2025-11-19 | Q3 2025 Earnings Release | |
| 2025-11-14 | Q2 2026 Earnings Release | |
| 2025-11-14 | Q2 2026 Earnings Release | |
| 2025-11-14 | Q3 2025 Earnings Release | |
| 2025-11-13 | Q3 2025 Earnings Release | |
| 2025-11-13 | Q3 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LLY Stock
- Calendar Eli Lilly and Company
Select your edition
All financial news and data tailored to specific country editions
















